Top

Published in:

Open Access 01-02-2019 | Review

Differential effects of dietary flavonoids on adipogenesis

Authors: Manizheh Khalilpourfarshbafi, Khadijeh Gholami, Dharmani Devi Murugan, Munavvar Zubaid Abdul Sattar, Nor Azizan Abdullah

Published in: European Journal of Nutrition | Issue 1/2019

Abstract

Propose

Obesity is a fast growing epidemic worldwide. During obesity, the increase in adipose tissue mass arise from two different mechanisms, namely, hyperplasia and hypertrophy. Hyperplasia which is the increase in adipocyte number is characteristic of severe obese patients. Recently, there has been much interest in targeting adipogenesis as therapeutic strategy against obesity. Flavonoids have been shown to regulate several pathways and affect a number of molecular targets during specific stages of adipocyte development.

Methods

Presently, we provide a review of key studies evaluating the effects of dietary flavonoids in different stages of adipocyte development with a particular emphasis on the investigations that explore the underlying mechanisms of action of these compounds in human or animal cell lines as well as animal models.

Results

Flavonoids have been shown to regulate several pathways and affect a number of molecular targets during specific stages of adipocyte development. Although most of the studies reveal anti-adipogenic effect of flavonoids, some flavonoids demonstrated proadipogenic effect in mesenchymal stem cells or preadipocytes.

Conclusion

The anti-adipogenic effect of flavonoids is mainly via their effect on regulation of several pathways such as induction of apoptosis, suppression of key adipogenic transcription factors, activation of AMPK and Wnt pathways, inhibition of clonal expansion, and cell-cycle arrest.

Gil-Campos M, Canete RR, Gil A (2004) Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 23(5):963–974. https://doi.org/10.1016/j.clnu.2004.04.010 CrossRefPubMed

World Health Organization (2014) Obesity and overweight (Fact sheet NO. 311). http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed 5 Feb 2016

Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among us adults, 1999–2008. JAMA 303(3):235–241. https://doi.org/10.1001/jama.2009.2014 CrossRefPubMed

Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner AE, Cushman SW, Periwal V (2009) Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput Biol 5(3):e1000324. https://doi.org/10.1371/journal.pcbi.1000324 CrossRefPubMedPubMedCentral

Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Naslund E, Britton T, Concha H, Hassan M, Ryden M, Frisen J, Arner P (2008) Dynamics of fat cell turnover in humans. Nature 453(7196):783–787. https://doi.org/10.1038/nature06902 CrossRefPubMed

Hirsch J, Batchelor B (1976) Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 5(2):299–311CrossRefPubMed

Lefterova MI, Lazar MA (2009) New developments in adipogenesis. Trends Endocrinol Metab 20(3):107–114. https://doi.org/10.1016/j.tem.2008.11.005 CrossRefPubMed

Vroegrijk IO, van Diepen JA, van den Berg SA, Romijn JA, Havekes LM, van Dijk KW, Darland G, Konda V, Tripp ML, Bland JS, Voshol PJ (2013) META060 protects against diet-induced obesity and insulin resistance in a high-fat-diet fed mouse. Nutrition 29(1):276–283. https://doi.org/10.1016/j.nut.2012.05.004 CrossRefPubMed

Bertoia ML, Rimm EB, Mukamal KJ, Hu FB, Willett WC, Cassidy A (2016) Dietary flavonoid intake and weight maintenance: three prospective cohorts of 124 086 US men and women followed for up to 24 years. BMJ. https://doi.org/10.1136/bmj.i17 CrossRefPubMedPubMedCentral

10.

Badshah H, Ullah I, Kim SE, Kim TH, Lee HY, Kim MO (2013) Anthocyanins attenuate body weight gain via modulating neuropeptide Y and GABAB1 receptor in rats hypothalamus. Neuropeptides 47(5):347–353. https://doi.org/10.1016/j.npep.2013.06.001 CrossRefPubMed

11.

Josic J, Olsson AT, Wickeberg J, Lindstedt S, Hlebowicz J (2010) Does green tea affect postprandial glucose, insulin and satiety in healthy subjects: a randomized controlled trial. Nutr J 9:63. https://doi.org/10.1186/1475-2891-9-63 CrossRefPubMedPubMedCentral

12.

Stendell-Hollis NR, Thomson CA, Thompson PA, Bea JW, Cussler EC, Hakim IA (2010) Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors. J Hum Nutr Diet 23(6):590–600. https://doi.org/10.1111/j.1365-277X.2010.01078.x CrossRefPubMedPubMedCentral

13.

Ashida H, Furuyashiki T, Nagayasu H, Bessho H, Sakakibara H, Hashimoto T, Kanazawa K (2004) Anti-obesity actions of green tea: possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis-related transcription factors. BioFactors 22(1–4):135–140CrossRefPubMed

14.

Westerterp-Plantenga MS, Lejeune MP, Kovacs EM (2005) Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res 13(7):1195–1204. https://doi.org/10.1038/oby.2005.142 CrossRefPubMed

15.

Moon J, Do HJ, Kim OY, Shin MJ (2013) Antiobesity effects of quercetin-rich onion peel extract on the differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats. Food Chem Toxicol 58:347–354. https://doi.org/10.1016/j.fct.2013.05.006 CrossRefPubMed

16.

Wolfram S, Raederstorff D, Wang Y, Teixeira SR, Elste V, Weber P (2005) TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Ann Nutr Metab 49(1):54–63. https://doi.org/10.1159/000084178 CrossRefPubMed

17.

Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L (2003) Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 138(1):24–32CrossRefPubMed

18.

Pallauf K, Duckstein N, Rimbach G (2017) A literature review of flavonoids and lifespan in model organisms. Proc Nutr Soc 76(2):145–162. https://doi.org/10.1017/s0029665116000720 CrossRefPubMed

19.

Niemela S, Miettinen S, Sarkanen JR, Ashammakhi N (2008) Adipose tissue and adipocyte differentiation: molecular and cellular aspects and tissue engineering In: Ashammakhi A, Reis R, Chiellini F (eds) Topics in tissue engineering, vol 4. University of Oulu, Oulu

20.

Rayalam S, Della-Fera MA, Baile CA (2008) Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem 19(11):717–726. https://doi.org/10.1016/j.jnutbio.2007.12.007 CrossRefPubMed

21.

Patel YM, Lane MD (2000) Mitotic clonal expansion during preadipocyte differentiation: calpain-mediated turnover of p27. J Biol Chem 275(23):17653–17660. https://doi.org/10.1074/jbc.M910445199 CrossRefPubMed

22.

Gregoire FM, Zhang F, Clarke HJ, Gustafson TA, Sears DD, Favelyukis S, Lenhard J, Rentzeperis D, Clemens LE, Mu Y, Lavan BE (2009) A novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema. Mol Endocrinol 23(7):975–988. https://doi.org/10.1210/me.2008-0473 CrossRefPubMedPubMedCentral

23.

Moreno-Navarrete J, Fernández-Real J (2012) Adipocyte differentiation. In: Symonds ME (ed) Adipose tissue biology. Springer, New York, pp 17–38. https://doi.org/10.1007/978-1-4614-0965-6_2 CrossRef

24.

Selvarajan S, Lund LR, Takeuchi T, Craik CS, Werb Z (2001) A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat Cell Biol 3(3):267–275. https://doi.org/10.1038/35060059 CrossRefPubMedPubMedCentral

25.

Zhao L, Gregoire F, Sul HS (2000) Transient induction of ENC-1, a Kelch-related actin-binding protein, is required for adipocyte differentiation. J Biol Chem 275(22):16845–16850CrossRefPubMed

26.

Mori T, Sakaue H, Iguchi H, Gomi H, Okada Y, Takashima Y, Nakamura K, Nakamura T, Yamauchi T, Kubota N, Kadowaki T, Matsuki Y, Ogawa W, Hiramatsu R, Kasuga M (2005) Role of Kruppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J Biol Chem 280(13):12867–12875. https://doi.org/10.1074/jbc.M410515200 CrossRefPubMed

27.

Oishi Y, Manabe I, Tobe K, Tsushima K, Shindo T, Fujiu K, Nishimura G, Maemura K, Yamauchi T, Kubota N, Suzuki R, Kitamura T, Akira S, Kadowaki T, Nagai R (2005) Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab 1(1):27–39. https://doi.org/10.1016/j.cmet.2004.11.005 CrossRefPubMed

28.

Li D, Yea S, Li S, Chen Z, Narla G, Banck M, Laborda J, Tan S, Friedman JM, Friedman SL, Walsh MJ (2005) Kruppel-like factor-6 promotes preadipocyte differentiation through histone deacetylase 3-dependent repression of DLK1. J Biol Chem 280(29):26941–26952. https://doi.org/10.1074/jbc.M500463200 CrossRefPubMed

29.

Fajas L, Fruchart JC, Auwerx J (1998) Transcriptional control of adipogenesis. Curr Opin Cell Biol 10(2):165–173CrossRefPubMed

30.

Reusch JE, Colton LA, Klemm DJ (2000) CREB activation induces adipogenesis in 3T3-L1 cells. Mol Cell Biol 20(3):1008–1020CrossRefPubMedPubMedCentral

31.

Zhang JW, Klemm DJ, Vinson C, Lane MD (2004) Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein beta gene during adipogenesis. J Biol Chem 279(6):4471–4478. https://doi.org/10.1074/jbc.M311327200 CrossRefPubMed

32.

Kanazawa A, Kawamura Y, Sekine A, Iida A, Tsunoda T, Kashiwagi A, Tanaka Y, Babazono T, Matsuda M, Kawai K, Iiizumi T, Fujioka T, Imanishi M, Kaku K, Iwamoto Y, Kawamori R, Kikkawa R, Nakamura Y, Maeda S (2005) Single nucleotide polymorphisms in the gene encoding Kruppel-like factor 7 are associated with type 2 diabetes. Diabetologia 48(7):1315–1322. https://doi.org/10.1007/s00125-005-1797-0 CrossRefPubMed

33.

Wu J, Srinivasan SV, Neumann JC, Lingrel JB (2005) The KLF2 transcription factor does not affect the formation of preadipocytes but inhibits their differentiation into adipocytes. Biochemistry 44(33):11098–11105. https://doi.org/10.1021/bi050166i CrossRefPubMed

34.

Tong Q, Tsai J, Tan G, Dalgin G, Hotamisligil Gö S (2005) Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. Mol Cell Biol 25(2):706–715. https://doi.org/10.1128/mcb.25.2.706-715.2005 CrossRefPubMedPubMedCentral

35.

Ge K, Guermah M, Yuan CX, Ito M, Wallberg AE, Spiegelman BM, Roeder RG (2002) Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. Nature 417(6888):563–567. https://doi.org/10.1038/417563a CrossRefPubMed

36.

Guermah M, Ge K, Chiang CM, Roeder RG (2003) The TBN protein, which is essential for early embryonic mouse development, is an inducible TAFII implicated in adipogenesis. Mol Cell 12:991–1001CrossRefPubMed

37.

Sarruf DA, Iankova I, Abella A, Assou S, Miard S, Fajas L (2005) Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma. Mol Cell Biol 25(22):9985–9995. https://doi.org/10.1128/mcb.25.22.9985-9995.2005 CrossRefPubMedPubMedCentral

38.

Abella A, Dubus P, Malumbres M, Rane SG, Kiyokawa H, Sicard A, Vignon F, Langin D, Barbacid M, Fajas L (2005) Cdk4 promotes adipogenesis through PPARgamma activation. Cell Metab 2(4):239–249. https://doi.org/10.1016/j.cmet.2005.09.003 CrossRefPubMed

39.

Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp PA, Hopkins N, Yaffe MB (2005) TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309(5737):1074–1078. https://doi.org/10.1126/science.1110955 CrossRefPubMed

40.

Yu C, Markan K, Temple KA, Deplewski D, Brady MJ, Cohen RN (2005) The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor γ transcriptional activity and repress 3T3-L1 adipogenesis. J Biol Chem 280:13600–13605CrossRefPubMed

41.

Grana X, Reddy EP (1995) Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11(2):211–219PubMed

42.

Hunter T, Pines J (1994) Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell 79(4):573–582CrossRefPubMed

43.

Hermeking H, Wolf DA, Kohlhuber F, Dickmanns A, Billaud M, Fanning E, Eick D (1994) Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. Proc Natl Acad Sci USA 91(22):10412–10416CrossRefPubMedPubMedCentral

44.

Heath VJ, Gillespie DA, Crouch DH (2000) Inhibition of the terminal stages of adipocyte differentiation by cMyc. Exp Cell Res 254(1):91–98. https://doi.org/10.1006/excr.1999.4736 CrossRefPubMed

45.

Tang QQ, Otto TC, Lane MD (2003) CCAAT/enhancerbinding protein b is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci USA 100:850–855CrossRefPubMedPubMedCentral

46.

Qin L, Chen Y, Niu Y, Chen W, Wang Q, Xiao S, Li A, Xie Y, Li J, Zhao X, He Z, Mo D (2010) A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway. BMC Genom 11:320. https://doi.org/10.1186/1471-2164-11-320 CrossRef

47.

Hamam D, Ali D, Kassem M, Aldahmash A, Alajez NM (2015) microRNAs as regulators of adipogenic differentiation of mesenchymal stem cells. Stem Cells Dev 24(4):417–425. https://doi.org/10.1089/scd.2014.0331 CrossRefPubMed

48.

Klöting N, Berthold S, Kovacs P, Schön MR, Fasshauer M, Ruschke K, Stumvoll M, Blüher M (2009) MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS ONE 4(3):e4699. https://doi.org/10.1371/journal.pone.0004699 CrossRefPubMedPubMedCentral

49.

Ortega FJ, Moreno-Navarrete JM, Pardo G, Sabater M, Hummel M, Ferrer A, Rodriguez-Hermosa JI, Ruiz B, Ricart W, Peral B, Fernández-Real JM (2010) MiRNA expression profi le of human subcutaneous adipose and during adipocyte differentiation. PLoS ONE 5(2):e9022CrossRefPubMedPubMedCentral

50.

Shi C, Huang F, Gu X, Zhang M, Wen J, Wang X, You L, Cui X, Ji C, Guo X (2016) Adipogenic miRNA and meta-signature miRNAs involved in human adipocyte differentiation and obesity. Oncotarget 7(26):40830–40845. https://doi.org/10.18632/oncotarget.8518 CrossRefPubMedPubMedCentral

51.

Mercado C, Eades G, Zhou Q (2013) MicroRNAs: a new class of master regulators of adipogenesis. Hum Genet Embryol 3:108CrossRef

52.

Knelangen JM, van der Hoek MB, Kong WC, Owens JA, Fischer B, Santos AN (2011) MicroRNA expression profile during adipogenic differentiation in mouse embryonic stem cells. Physiol Genomics 43(10):611–620. https://doi.org/10.1152/physiolgenomics.00116.2010 CrossRefPubMed

53.

Xie H, Lim B, Lodish HF (2009) MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58(5):1050–1057. https://doi.org/10.2337/db08-1299 CrossRefPubMedPubMedCentral

54.

Zaragosi LE, Wdziekonski B, Brigand KL, Villageois P, Mari B, Waldmann R, Dani C, Barbry P (2011) Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol 12(7):R64. https://doi.org/10.1186/gb-2011-12-7-r64 CrossRefPubMedPubMedCentral

55.

Hilton C, Neville MJ, Karpe F (2013) MicroRNAs in adipose tissue: their role in adipogenesis and obesity. Int J Obes 37(3):325–332CrossRef

56.

Huang J, Zhao L, Xing L, Chen D (2010) MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 28(2):357–364. https://doi.org/10.1002/stem.288 CrossRefPubMedPubMedCentral

57.

Karbiener M, Fischer C, Nowitsch S, Opriessnig P, Papak C, Ailhaud G, Dani C, Amri EZ, Scheideler M (2009) microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem Biophys Res Commun 390(2):247–251. https://doi.org/10.1016/j.bbrc.2009.09.098 CrossRefPubMed

58.

Kim SY, Kim AY, Lee HW, Son YH, Lee GY, Lee JW, Lee YS, Kim JB (2010) miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun 392(3):323–328. https://doi.org/10.1016/j.bbrc.2010.01.012 CrossRefPubMed

59.

Lin Q, Gao Z, Alarcon RM, Ye J, Yun Z (2009) A role of miR-27 in the regulation of adipogenesis. FEBS J 276(8):2348–2358CrossRefPubMedPubMedCentral

60.

Sun T, Fu M, Bookout AL, Kliewer SA, Mangelsdorf DJ (2009) MicroRNA let-7 regulates 3T3-L1 adipogenesis. Mol Endocrinol 23(6):925–931. https://doi.org/10.1210/me.2008-0298 CrossRefPubMedPubMedCentral

61.

Kinoshita M, Ono K, Horie T, Nagao K, Nishi H, Kuwabara Y, Takanabe-Mori R, Hasegawa K, Kita T, Kimura T (2010) Regulation of adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2AR and 5-HT2CR and involvement of microRNA-448-mediated repression of KLF5. Mol Endocrinol 24(10):1978–1987. https://doi.org/10.1210/me.2010-0054 CrossRefPubMedPubMedCentral

62.

Kawai M, Green CB, Lecka-Czernik B, Douris N, Gilbert MR, Kojima S, Ackert-Bicknell C, Garg N, Horowitz MC, Adamo ML, Clemmons DR, Rosen CJ (2010) A circadian-regulated gene, Nocturnin, promotes adipogenesis by stimulating PPAR-gamma nuclear translocation. Proc Natl Acad Sci USA 107(23):10508–10513. https://doi.org/10.1073/pnas.1000788107 CrossRefPubMedPubMedCentral

63.

Costa MJ, So AY, Kaasik K, Krueger KC, Pillsbury ML, Fu YH, Ptacek LJ, Yamamoto KR, Feldman BJ (2011) Circadian rhythm gene period 3 is an inhibitor of the adipocyte cell fate. J Biol Chem 286(11):9063–9070. https://doi.org/10.1074/jbc.M110.164558 CrossRefPubMedPubMedCentral

64.

Guo B, Chatterjee S, Li L, Kim JM, Lee J, Yechoor VK, Minze LJ, Hsueh W, Ma K (2012) The clock gene, brain and muscle Arnt-like 1, regulates adipogenesis via Wnt signaling pathway. FASEB J 26(8):3453–3463. https://doi.org/10.1096/fj.12-205781 CrossRefPubMedPubMedCentral

65.

Shimba S, Ishii N, Ohta Y, Ohno T, Watabe Y, Hayashi M, Wada T, Aoyagi T, Tezuka M (2005) Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, regulates adipogenesis. Proc Natl Acad Sci USA 102(34):12071–12076. https://doi.org/10.1073/pnas.0502383102 CrossRefPubMedPubMedCentral

66.

Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, Kahn CR (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3(1):25–38CrossRefPubMed

67.

Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR, McNeish JD, Coleman KG (2003) Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ. J Clin Invest 112(2):197–208. https://doi.org/10.1172/jci200316885 CrossRefPubMedPubMedCentral

68.

Kim JE, Chen J (2004) Regulation of peroxisome proliferator-activated receptor-g activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 53:2748–2756CrossRefPubMed

69.

Ortega FJ, Moreno-Navarrete JM, Ribas V, Esteve E, Rodriguez-Hermosa JI, Ruiz B, Peral B, Ricart W, Zorzano A, Fernandez-Real JM (2009) Subcutaneous fat shows higher thyroid hormone receptor-alpha1 gene expression than omental fat. Obesity (Silver Spring) 17(12):2134–2141. https://doi.org/10.1038/oby.2009.110 CrossRef

70.

Hutley L, Shurety W, Newell F, McGeary R, Pelton N, Grant J, Herington A, Cameron D, Whitehead J, Prins J (2004) Fibroblast growth factor 1: a key regulator of human adipogenesis. Diabetes 53(12):3097–3106CrossRefPubMed

71.

Kakudo N, Shimotsuma A, Kusumoto K (2007) Fibroblast growth factor-2 stimulates adipogenic differentiation of human adipose-derived stem cells. Biochem Biophys Res Commun 359(2):239–244. https://doi.org/10.1016/j.bbrc.2007.05.070 CrossRefPubMed

72.

Ohta H, Konishi M, Itoh N (2011) FGF10 and FGF21 as regulators in adipocyte development and metabolism. Endocr Metab Immune Disord Drug Targets 11(4):302–309CrossRefPubMed

73.

Moldes M, Zuo Y, Morrison RF, Silva D, Park BH, Liu J, Farmer SR (2003) Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. Biochem J 376(Pt 3):607–613. https://doi.org/10.1042/bj20030426 CrossRefPubMedPubMedCentral

74.

Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA (2000) Inhibition of adipogenesis by Wnt signaling. Science 289(5481):950–953CrossRefPubMed

75.

Marion V, Stoetzel C, Schlicht D, Messaddeq N, Koch M, Flori E, Danse JM, Mandel JL, Dollfus H (2009) Transient ciliogenesis involving Bardet-Biedl syndrome proteins is a fundamental characteristic of adipogenic differentiation. Proc Natl Acad Sci USA 106(6):1820–1825. https://doi.org/10.1073/pnas.0812518106 CrossRefPubMedPubMedCentral

76.

Choy L, Derynck R (2003) Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J Biol Chem 278(11):9609–9619. https://doi.org/10.1074/jbc.M212259200 CrossRefPubMed

77.

Ninomiya-Tsuji J, Torti FM, Ringold GM (1993) Tumor necrosis factor-induced c-myc expression in the absence of mitogenesis is associated with inhibition of adipocyte differentiation. Proc Natl Acad Sci USA 90(20):9611–9615CrossRefPubMedPubMedCentral

78.

Yarmo MN, Landry A, Molgat AS, Gagnon A, Sorisky A (2009) Macrophage-conditioned medium inhibits differentiation-induced Rb phosphorylation in 3T3-L1 preadipocytes. Exp Cell Res 315(3):411–418. https://doi.org/10.1016/j.yexcr.2008.10.036 CrossRefPubMed

79.

Constant VA, Gagnon A, Landry A, Sorisky A (2006) Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia 49(6):1402–1411. https://doi.org/10.1007/s00125-006-0253-0 CrossRefPubMed

80.

Lumeng CN, Deyoung SM, Saltiel AR (2007) Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab 292(1):E166–E174. https://doi.org/10.1152/ajpendo.00284.2006 CrossRef

81.

He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM (2003) Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci USA 100(26):15712–15717. https://doi.org/10.1073/pnas.2536828100 CrossRefPubMedPubMedCentral

82.

Leonardini A, Laviola L, Perrini S, Natalicchio A, Giorgino F (2009) Cross-talk between PPARgamma and insulin signaling and modulation of insulin sensitivity. PPAR Res 2009:818945. https://doi.org/10.1155/2009/818945 CrossRefPubMed

83.

Cock TA, Houten SM, Auwerx J (2004) Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm. EMBO Rep 5(2):142–147. https://doi.org/10.1038/sj.embor.7400082 CrossRefPubMedPubMedCentral

84.

Guarente L (2006) Sirtuins as potential targets for metabolic syndrome. Nature 444(7121):868–874. https://doi.org/10.1038/nature05486 CrossRefPubMed

85.

Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado de Oliveira R, Leid M, McBurney MW, Guarente L (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-[gamma]. Nature 429(6993):771–776CrossRefPubMedPubMedCentral

86.

Qiang L, Wang L, Kon N, Zhao W, Lee S, Zhang Y, Rosenbaum M, Zhao Y, Gu W, Farmer SR, Accili D (2012) Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Ppargamma. Cell 150(3):620–632. https://doi.org/10.1016/j.cell.2012.06.027 CrossRefPubMedPubMedCentral

87.

van Beekum O, Fleskens V, Kalkhoven E (2009) Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator. Obesity (Silver Spring) 17(2):213–219. https://doi.org/10.1038/oby.2008.473 CrossRef

88.

Choi JH, Banks AS, Estall JL, Kajimura S, Bostrom P, Laznik D, Ruas JL, Chalmers MJ, Kamenecka TM, Bluher M, Griffin PR, Spiegelman BM (2010) Obesity-linked phosphorylation of PPARγ by cdk5 is a direct target of the anti-diabetic PPARγ ligands. Nature 466(7305):451–456. https://doi.org/10.1038/nature09291 CrossRefPubMedPubMedCentral

89.

Cushnie TP, Lamb AJ (2005) Antimicrobial activity of flavonoids. Int J Antimicrob Agents 26(5):343–356CrossRefPubMedPubMedCentral

90.

Falcone Ferreyra ML, Rius SP, Casati P (2012) Flavonoids: biosynthesis, biological functions, and biotechnological applications. Front Plant Sci 3:222. https://doi.org/10.3389/fpls.2012.00222 CrossRefPubMedPubMedCentral

91.

Winkel-Shirley B (2001) Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol 126(2):485–493. https://doi.org/10.1104/pp.126.2.485 CrossRefPubMedPubMedCentral

92.

Zhang ZF, Lu J, Zheng YL, Wu DM, Hu B, Shan Q, Cheng W, Li MQ, Sun YY (2013) Purple sweet potato color attenuates hepatic insulin resistance via blocking oxidative stress and endoplasmic reticulum stress in high-fat-diet-treated mice. J Nutr Biochem 24(6):1008–1018. https://doi.org/10.1016/j.jnutbio.2012.07.009 CrossRefPubMed

93.

Pompei A, Toniato E, Innocenti P, I DA, Cellini C, Mattoscio D, Cotellese R, Bosco D, Ciccarelli R, Dadorante V, N DO, Martinotti S, Robuffo I (2012) Cyanidin reduces preadipocyte differentiation and relative ChREBP expression. J Biol Regul Homeost Agents 26(2):253–264PubMed

94.

Kim HK, Kim JN, Han SN, Nam JH, Na HN, Ha TJ (2012) Black soybean anthocyanins inhibit adipocyte differentiation in 3T3-L1 cells. Nutr Res 32(10):770–777. https://doi.org/10.1016/j.nutres.2012.06.008 CrossRefPubMed

95.

Matsukawa T, Inaguma T, Han J, Villareal MO, Isoda H (2015) Cyanidin-3-glucoside derived from black soybeans ameliorate type 2 diabetes through the induction of differentiation of preadipocytes into smaller and insulin-sensitive adipocytes. J Nutr Biochem 26(8):860–867. https://doi.org/10.1016/j.jnutbio.2015.03.006 CrossRefPubMed

96.

Crozier A, Jaganath IB, Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26(8):1001–1043. https://doi.org/10.1039/b802662a CrossRefPubMed

97.

Ono M, Fujimori K (2011) Antiadipogenic effect of dietary apigenin through activation of AMPK in 3T3-L1 cells. J Agric Food Chem 59(24):13346–13352. https://doi.org/10.1021/jf203490a CrossRefPubMed

98.

Habinowski SA, Witters LA (2001) The effects of AICAR on adipocyte differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 286(5):852–856. https://doi.org/10.1006/bbrc.2001.5484 CrossRefPubMed

99.

Beecher GR (2003) Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 133(10):3248s–3254sCrossRefPubMed

100.

Hajiaghaalipour F, Khalilpourfarshbafi M, Arya A (2015) Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus. Int J Biol Sci 11(5):508–524. https://doi.org/10.7150/ijbs.11241 CrossRefPubMedPubMedCentral

101.

Matsuda H, Kogami Y, Nakamura S, Sugiyama T, Ueno T, Yoshikawa M (2011) Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells. Bioorg Med Chem 19(9):2835–2841. https://doi.org/10.1016/j.bmc.2011.03.040 CrossRefPubMed

102.

He J, Giusti MM (2010) Anthocyanins: natural colorants with health-promoting properties. Annu Rev Food Sci Technol 1:163–187. https://doi.org/10.1146/annurev.food.080708.100754 CrossRefPubMed

103.

Ghosh D, Konishi T (2007) Anthocyanins and anthocyanin-rich extracts: role in diabetes and eye function. Asia Pac J Clin Nutr 16(2):200–208PubMed

104.

Sakurai N, Mochizuki K, Kameji H, Shimada M, Goda T (2009) (−)-Epigallocatechin gallate enhances the expression of genes related to insulin sensitivity and adipocyte differentiation in 3T3-L1 adipocytes at an early stage of differentiation. Nutrition 25(10):1047–1056. https://doi.org/10.1016/j.nut.2009.02.012 CrossRefPubMed

105.

Shin DW, Kim SN, Lee SM, Lee W, Song MJ, Park SM, Lee TR, Baik JH, Kim HK, Hong JH, Noh M (2009) (−)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivation. Biochem Pharmacol 77(1):125–133. https://doi.org/10.1016/j.bcp.2008.09.033 CrossRefPubMed

106.

Park UH, Jeong JC, Jang JS, Sung MR, Youn H, Lee SJ, Kim EJ, Um SJ (2012) Negative regulation of adipogenesis by kaempferol, a component of Rhizoma Polygonati falcatum in 3T3-L1 cells. Biol Pharm Bull 35(9):1525–1533CrossRefPubMed

107.

Kim MA, Kang K, Lee HJ, Kim M, Kim CY, Nho CW (2014) Apigenin isolated from Daphne genkwa Siebold et Zucc. inhibits 3T3-L1 preadipocyte differentiation through a modulation of mitotic clonal expansion. Life Sci 101:64–72CrossRefPubMed

108.

Park HS, Kim SH, Kim YS, Ryu SY, Hwang JT, Yang HJ, Kim GH, Kwon DY, Kim MS (2009) Luteolin inhibits adipogenic differentiation by regulating PPARgamma activation. BioFactors 35(4):373–379. https://doi.org/10.1002/biof.38 CrossRefPubMed

109.

Chun OK, Chung SJ, Song WO (2007) Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr 137:1244–1252CrossRefPubMed

110.

Babu PVA, Liu D, Gilbert ER (2013) Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem. https://doi.org/10.1016/j.jnutbio.2013.06.003 CrossRefPubMedPubMedCentral

111.

Furuyashiki T, Nagayasu H, Aoki Y, Bessho H, Hashimoto T, Kanazawa K, Ashida H (2004) Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARgamma2 and C/EBPalpha in 3T3-L1 cells. Biosci Biotechnol Biochem 68(11):2353–2359. https://doi.org/10.1271/bbb.68.2353 CrossRefPubMed

112.

Lee H, Bae S, Yoon Y (2013) The anti-adipogenic effects of (−)epigallocatechin gallate are dependent on the WNT/beta-catenin pathway. J Nutr Biochem 24(7):1232–1240. https://doi.org/10.1016/j.jnutbio.2012.09.007 CrossRefPubMed

113.

Lin J, Della-Fera MA, Baile CA (2005) Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes. Obes Res 13(6):982–990. https://doi.org/10.1038/oby.2005.115 CrossRefPubMed

114.

Lee J, Jung E, Lee J, Kim S, Huh S, Kim Y, Kim Y, Byun SY, Kim YS, Park D (2009) Isorhamnetin represses adipogenesis in 3T3-L1 cells. Obesity (Silver Spring) 17(2):226–232. https://doi.org/10.1038/oby.2008.472 CrossRef

115.

Lee J, Lee J, Jung E, Hwang W, Kim YS, Park D (2010) Isorhamnetin-induced anti-adipogenesis is mediated by stabilization of beta-catenin protein. Life Sci 86(11–12):416–423. https://doi.org/10.1016/j.lfs.2010.01.012 CrossRefPubMed

116.

Fischer-Posovszky P, Kukulus V, Tews D, Unterkircher T, Debatin KM, Fulda S, Wabitsch M (2010) Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner. Am J Clin Nutr 92(1):5–15. https://doi.org/10.3945/ajcn.2009.28435 CrossRefPubMed

117.

Kim SC, Kim YH, Son SW, Moon EY, Pyo S, Um SH (2015) Fisetin induces Sirt1 expression while inhibiting early adipogenesis in 3T3-L1 cells. Biochem Biophys Res Commun 467(4):638–644. https://doi.org/10.1016/j.bbrc.2015.10.094 CrossRefPubMed

118.

Lee YJ, Choi HS, Seo MJ, Jeon HJ, Kim KJ, Lee BY (2015) Kaempferol suppresses lipid accumulation by inhibiting early adipogenesis in 3T3-L1 cells and zebrafish. Food Funct 6(8):2824–2833CrossRefPubMed

119.

Zhang M, Ikeda K, Xu JW, Yamori Y, Gao XM, Zhang BL (2009) Genistein suppresses adipogenesis of 3T3-L1 cells via multiple signal pathways. Phytother Res 23(5):713–718. https://doi.org/10.1002/ptr.2724 CrossRefPubMed

120.

Takenouchi T, Takayama Y, Takezawa T (2004) Co-treatment with dexamethasone and octanoate induces adipogenesis in 3T3-L1 cells. Cell Biol Int 28(3):209–216. https://doi.org/10.1016/j.cellbi.2003.11.020 CrossRefPubMed

121.

Yarwood SJ, Sale EM, Sale GJ, Houslay MD, Kilgour E, Anderson NG (1999) Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling. J Biol Chem 274(13):8662–8668CrossRefPubMed

122.

Ji SY, Choi KM, Lee YS, Yu JY, Shin DM, Lee S, Yoo KS, Lee YM, Yun YP, Yoo HS (2012) Rhamnetin-induced suppression of clonal expansion during early stage of adipogenesis. Arch Pharm Res 35(6):1083–1089. https://doi.org/10.1007/s12272-012-0616-7 CrossRefPubMed

123.

Hsu CL, Yen GC (2006) Induction of cell apoptosis in 3T3-L1 pre-adipocytes by flavonoids is associated with their antioxidant activity. Mol Nutr Food Res 50(11):1072–1079. https://doi.org/10.1002/mnfr.200600040 CrossRefPubMed

124.

Hsu CL, Yen GC (2007) Effects of flavonoids and phenolic acids on the inhibition of adipogenesis in 3T3-L1 adipocytes. J Agric Food Chem 55(21):8404–8410CrossRefPubMed

125.

Choi I, Park Y, Choi H, Lee EH (2006) Anti-adipogenic activity of rutin in 3T3-L1 cells and mice fed with high-fat diet. BioFactors 26(4):273–281CrossRefPubMed

126.

Manach C, Williamson G, Morand C, Scalbert A, Rémésy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81(1):230S–242SCrossRefPubMed

127.

Serafini M, Peluso I, Raguzzini A (2010) Flavonoids as anti-inflammatory agents. Proc Nutr Soc 69(3):273–278. https://doi.org/10.1017/s002966511000162x CrossRefPubMed

128.

Thilakarathna SH, Rupasinghe HPV (2013) Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 5(9):3367–3387. https://doi.org/10.3390/nu5093367 CrossRefPubMedPubMedCentral

129.

Ahn J, Lee H, Kim S, Park J, Ha T (2008) The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun 373(4):545–549CrossRefPubMed

130.

Subash-Babu P, Alshatwi AA (2015) Hesperetin inhibit adipocyte differentiation and enhance Bax- and p21-mediated adipolysis in human mesenchymal stem cell adipogenesis. J Biochem Mol Toxicol 29(3):99–108. https://doi.org/10.1002/jbt.21672 CrossRefPubMed

131.

Kim MH, Park JS, Seo MS, Jung JW, Lee YS, Kang KS (2010) Genistein and daidzein repress adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells via Wnt/beta-catenin signalling or lipolysis. Cell Prolif 43(6):594–605. https://doi.org/10.1111/j.1365-2184.2010.00709.x CrossRefPubMed

132.

de Boer VCJ, Dihal AA, van der Woude H, Arts ICW, Wolffram S, Alink GM, Rietjens IMCM, Keijer J, Hollman PCH (2005) Tissue distribution of quercetin in rats and pigs. J Nutr 135(7):1718–1725. https://doi.org/10.1093/jn/135.7.1718 CrossRefPubMed

133.

Nakao Y, Yoshihara H, Fujimori K (2016) Suppression of very early stage of adipogenesis by Baicalein, a Plant-derived flavonoid through reduced Akt-C/EBPα-GLUT4 signaling-mediated glucose uptake in 3T3-L1 adipocytes. PLoS ONE 11(9):e0163640. https://doi.org/10.1371/journal.pone.0163640 CrossRefPubMedPubMedCentral

134.

Kurylowicz A (2016) In search of new therapeutic targets in obesity treatment: Sirtuins. Int J Mol Sci 17(4):572. https://doi.org/10.3390/ijms17040572 CrossRefPubMedCentral

135.

Chalkiadaki A, Guarente L (2012) High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction. Cell Metab 16(2):180–188. https://doi.org/10.1016/j.cmet.2012.07.003 CrossRefPubMedPubMedCentral

136.

Abdesselem H, Madani A, Hani A, Al-Noubi M, Goswami N, Ben Hamidane H, Billing AM, Pasquier J, Bonkowski MS, Halabi N, Dalloul R, Sheriff MZ, Mesaeli N, ElRayess M, Sinclair DA, Graumann J, Mazloum NA (2016) SIRT1 limits adipocyte hyperplasia through c-Myc inhibition. J Biol Chem 291(5):2119–2135. https://doi.org/10.1074/jbc.M115.675645 CrossRefPubMed

137.

Escande C, Nin V, Price NL, Capellini V, Gomes AP, Barbosa MT, O’Neil L, White TA, Sinclair DA, Chini EN (2013) Flavonoid apigenin is an inhibitor of the NAD(+)ase CD38: implications for cellular NAD(+) metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes 62(4):1084–1093CrossRefPubMedPubMedCentral

138.

Jang WS, Seo CR, Jang HH, Song NJ, Kim JK, Ahn JY, Han J, Seo WD, Lee YM, Park KW (2015) Black rice (Oryza sativa L.) extracts induce osteoblast differentiation and protect against bone loss in ovariectomized rats. Food Funct 6(1):265–275. https://doi.org/10.1039/c4fo00836g CrossRefPubMed

139.

Chein PO, Chen YC, Lu SC, Sheu F (2005) Dietary flavonoids suppress adipogenesis in 3T3-L1 preadipocytes. JFDA 13(2):168–175

140.

Jung CH, Kim H, Ahn J, Jeon TI, Lee DH, Ha TY (2013) Fisetin regulates obesity by targeting mTORC1 signaling. J Nutr Biochem 24(8):1547–1554. https://doi.org/10.1016/j.jnutbio.2013.01.003 CrossRefPubMed

141.

Lee Y, Bae EJ (2013) Inhibition of mitotic clonal expansion mediates fisetin-exerted prevention of adipocyte differentiation in 3T3-L1 cells. Arch Pharm Res 36(11):1377–1384. https://doi.org/10.1007/s12272-013-0226-z CrossRefPubMed

142.

Watanabe M, Hisatake M, Fujimori K (2015) Fisetin suppresses lipid accumulation in mouse adipocytic 3T3-L1 cells by repressing GLUT4-mediated glucose uptake through inhibition of mTOR-C/EBPalpha signaling. J Agric Food Chem 63(20):4979–4987. https://doi.org/10.1021/acs.jafc.5b00821 CrossRefPubMed

143.

Jae-Sik J, Ji-Cheon J (2010) Anti-adipogenic effect of Kaempferol, a component of Polygonati Rhizoma. J Korean Orient Med 31(2):158–166

144.

Wang Q, Wang ST, Yang X, You PP, Zhang W (2015) Myricetin suppresses differentiation of 3T3-L1 preadipocytes and enhances lipolysis in adipocytes. Nutr Res 35(4):317–327. https://doi.org/10.1016/j.nutres.2014.12.009 CrossRefPubMed

145.

Bin H-S, Choi U-K (2012) Myricetin inhibits adipogenesis in human adipose tissue-derived mesenchymal stem cells. Food Sci Biotechnol 21(5):1391CrossRef

146.

Naowaboot J, Chung CH, Choi R (2015) Rutin stimulates adipocyte differentiation and adiponectin secretion in 3T3-L1 adipocytes. J Med Assoc Thai 98(Suppl 3):S1–S6

147.

Swick J, Lee OK, Kim YC (2012) Quercetin exerts anti-adipogenic effects through modulation of 3T3-L1 preadipocyte proliferation and differentiation. FASEB J 26:644

148.

Seo YS, Kang OH, Kim SB, Mun SH, Kang DH, Yang DW, Choi JG, Lee YM, Kang DK, Lee HS, Kwon DY (2015) Quercetin prevents adipogenesis by regulation of transcriptional factors and lipases in OP9 cells. Int J Mol Med 35(6):1779–1785. https://doi.org/10.3892/ijmm.2015.2185 CrossRefPubMed

149.

Richard AJ, Amini-Vaughan Z, Ribnicky DM, Stephens JM (2013) Naringenin inhibits adipogenesis and reduces insulin sensitivity and adiponectin expression in adipocytes. Evid Based Complement Alternat Med 2013:549750. https://doi.org/10.1155/2013/549750 CrossRefPubMedPubMedCentral

150.

Su SJ, Yeh YT, Su SH, Chang KL, Shyu HW, Chen KM, Yeh H (2013) Biochanin a promotes osteogenic but inhibits adipogenic differentiation: evidence with primary adipose-derived stem cells. Evid Based Complement Alternat Med 2013:846039. https://doi.org/10.1155/2013/846039 CrossRefPubMedPubMedCentral

151.

Yu SY, Choi Y, Kwon YI, Wood R, Kim YC (2015) Formononetin enhances the expression of genes related to adipocyte differentiation and insulin sensitivity. FASEB J 29

152.

Choi Y, Noh J, Yun SW, Kwon YI, Kim YC (2013) Effect of isoflavones from Astragalus membranaceus on 3T3-L1 adipocyte differentiation and insulin sensitivity. FASEB J 27:637–628

153.

Harmon AW, Harp JB (2001) Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am J Physiol Cell Physiol 280(4):C807–C813CrossRef

154.

Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, Ha J, Park OJ (2005) Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 338(2):694–699. https://doi.org/10.1016/j.bbrc.2005.09.195 CrossRefPubMed

155.

Lee K, Villena JA, Moon YS, Kim KH, Lee S, Kang C, Sul HS (2003) Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest 111(4):453–461. https://doi.org/10.1172/jci15924 CrossRefPubMedPubMedCentral

156.

Braune A, Blaut M (2016) Bacterial species involved in the conversion of dietary flavonoids in the human gut. Gut Microbes 7(3):216–234. https://doi.org/10.1080/19490976.2016.1158395 CrossRefPubMedPubMedCentral

157.

Egert S, Rimbach G (2011) Which sources of flavonoids: complex diets or dietary supplements? Adv Nutr 2(1):8–14. https://doi.org/10.3945/an.110.000026 CrossRefPubMedPubMedCentral

Title: Differential effects of dietary flavonoids on adipogenesis
Authors: Manizheh Khalilpourfarshbafi
Khadijeh Gholami
Dharmani Devi Murugan
Munavvar Zubaid Abdul Sattar
Nor Azizan Abdullah
Publication date: 01-02-2019
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nutrition / Issue 1/2019
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-018-1663-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Differential effects of dietary flavonoids on adipogenesis

Abstract

Propose

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Propose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2019

The relationship between the dietary inflammatory index and prevalence of radiographic symptomatic osteoarthritis: data from the Osteoarthritis Initiative

Effects of hydration on plasma copeptin, glycemia and gluco-regulatory hormones: a water intervention in humans

A priori dietary patterns and blood pressure in the EPIC Florence cohort: a cross-sectional study

The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect

The impact of probiotic supplementation during pregnancy on DNA methylation of obesity-related genes in mothers and their children

Tea and coffee consumption in relation to glioma: a case-control study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page